https://www.merck.com/news/merck-announces-second-quarter-2022-financial-results/
Merck Delivers Robust Sales Growth and Important Clinical Advancements in Second Quarter Second-Quarter 2022 Worldwide Sales Were $14.6 Billion, an Increase of 28% From Second Quarter 2021; LAGEVRIO Sales Were $1.2 Billion, Growth Excluding LAGEVRIO Was 18%; …
Create an account or login to join the discussion